Rojo-López M.I., Bermúdez-López M., Castro E., Farràs C., Torres G., Pamplona R., Lecube A., Valdivielso J.M., Fernández E., Julve J., Castelblanco E., Franch-Nadal J., Alonso N., Granado-Casas M., Mauricio D., Miquel E., Ortega M., Barbé F., González J., Barril S., Sánchez-de-la-Torre M., Portero-Otín M., Jové M., Hernández M., Rius F., Godoy P., Alonso M.M.. Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort. ATHEROSCLEROSIS. 2023; 380DOI:10.1016/j.atherosclerosis.2023.117191. PMID:37586219. IF:4.900(Q1/2D).

Dieberger A.M., Obermayer-Pietsch B., Harreiter J., Desoye G., van Poppel M.N.M., Simmons D., Corcoy R., Perez J.M.A., Kautzky-Willer A., Damm P., Mathiesen E., Jensen D.M., Andersen L.L.T., Dunne F., Lapolla A., Dalfra M.G., Bertolotto A., Jelsma J.G.M., Galjaard S., Wender-Ozegowska E., Zawiejska A., Hill D., Devlieger R., Snoek F.J.. Physical activity and sedentary time across pregnancy and associations with neonatal weight, adiposity and cord blood parameters: a secondary analysis of the DALI study. INTERNATIONAL JOURNAL OF OBESITY. 2023; 47(9)DOI:10.1038/s41366-023-01347-9. PMID:37500924. IF:4.200(Q1/3D).

Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. Endocrinologia Diabetes y Nutricion. 2023; 70(7)DOI:10.1016/j.endinu.2023.02.002. PMID:37268528. IF:1.800(Q3/8D).

Velilla T.A., Guijarro C., Ruiz R.C., Piñero M.R., Marcos J.F.V., Pérez A.P., López M.A.B., López A.M., Donaire J.A.G., Obaya J.C., Guerra L.C., Carratalá V.P., Cabello I.E., Lazo M.S., Rodrigo M.M.C., Prieto J.M.M., Doblas J.J.G., Soto A.B.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should a basic lipid profile include?. Neurology Perspectives. 2023; 3(2)DOI:10.1016/j.neurop.2023.100126. PMID:. IF:(Q/D).

Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. Rec: Cardioclinics. 2023; 58(2)DOI:10.1016/j.rccl.2022.11.004. PMID:. IF:(Q/D).

Bellido V., Freckman G., Pérez A., Galindo R.J.. Accuracy and Potential Interferences of Continuous Glucose Monitoring Sensors in the Hospital. Endocrine Practice. 2023; 29(11)DOI:10.1016/j.eprac.2023.06.007. PMID:37369291. IF:3.700(Q2/4D).

Niño-Narvión J., Camacho M., Julve J.. NAD+ Precursors: A Physiological Reboot?. Nutrients. 2023; 15(20)DOI:10.3390/nu15204479. PMID:. IF:(Q/D).

O'Toole, D, Kunz, PL, Webb, SM, Goldstein, G, Khawaja, S, McDonnell, M, Boiziau, S, Gueguen, D, Houchard, A, Jr, ARO, Prebtani, A. PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly. ADVANCES IN THERAPY. 2023; 40(2)DOI:10.1007/s12325-022-02360-6. PMID:36502449. IF:3.400(Q2/3D).

Webb S.M., Valassi E.. Quality of life in pituitary diseases. Endocrinologia Diabetes y Nutricion. 2023; 70(7)DOI:10.1016/j.endinu.2023.03.001. PMID:. IF:(Q/D).

Reiniš J., Petrenko O., Simbrunner B., Hofer B.S., Schepis F., Scoppettuolo M., Saltini D., Indulti F., Guasconi T., Albillos A., Téllez L., Villanueva C., Brujats A., Garcia-Pagan J.C., Perez-Campuzano V., Hernández-Gea V., Rautou P.-E., Moga L., Vanwolleghem T., Kwanten W.J., Francque S., Trebicka J., Gu W., Ferstl P.G., Gluud L.L., Bendtsen F., Møller S., Kubicek S., Mandorfer M., Reiberger T.. Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis. JOURNAL OF HEPATOLOGY. 2023; 78(2)DOI:10.1016/j.jhep.2022.09.012. PMID:36152767. IF:26.800(Q1/1D).

Sánchez-Ocaña R., Foruny Olcina J.R., Vila Costas J., Gallego Rojo F., Jiménez Pérez J., Domínguez-Muñoz E., González Huix F., Pons Beltrán V., Gornals Soler J., Sánchez Hernández E., Gómez Oliva C., Dolz Abadía C., Aparicio Tormo J.R.. SEED Consensus Document on SpyGlass-DS. Gastroenterologia y Hepatologia. 2023; 46(1)DOI:10.1016/j.gastrohep.2022.08.012. PMID:36179947. IF:2.200(Q3/6D).

Carrión J.A., Graupera I., Vergara M., Morillas R.M., Pericàs J.M., Poca M., Amador A., Fernández R., Monllor T., Muñoz L., Bartres C., Genescà J., Ginés P., Forns X.. Position paper of the Catalan Society of Gastroenterology about hepatic elastography 2022. Gastroenterologia y Hepatologia. 2023; 46(9)DOI:10.1016/j.gastrohep.2022.11.005. PMID:36435378. IF:2.200(Q3/6D).

Chaparro M., Acosta D., Rodríguez C., Mesonero F., Vicuña M., Barreiro-De Acosta M., Fernández-Clotet A., Hernández Martínez Á., Arroyo M., Vera I., Ruiz-Cerulla A., Sicilia B., Cabello Tapia M.J., Muñoz Villafranca C., Castro-Poceiro J., Martínez Cadilla J., Sierra-Ausín M., Vázquez Morón J.M., Vicente Lidón R., Bermejo F., Royo V., Calafat M., González-Muñoza C., Leo Carnerero E., Manceñido Marcos N., Torrealba L., Alonso-Galán H., Benítez J.M., Ber Nieto Y., Diz-Lois Palomares M.T., García M.J., Muñoz J.F., Armesto González E.M., Calvet X., Hernández-Camba A., Madrigal Domínguez R.E., Menchén L., Pérez Calle J.L., Piqueras M., Dueñas Sadornil C., Botella B., Martínez-Pérez T.D.J., Ramos L., Rodríguez-Grau M.C., San Miguel E., Fernández Forcelledo J.L., Fradejas Salazar P.M., García-Sepulcre M., Gutiérrez A., Llaó J., Sesé Abizanda E., Boscá-Watts M., Iyo E., Keco-Huerga A., Martínez Bonil C., Peña González E., Pérez-Galindo P., Varela P., Gisbert J.P.. Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2023; 118(7)DOI:10.14309/ajg.0000000000002145. PMID:36716287. IF:8.500(Q1/1D).

Villanueva C., Tripathi D.. Carvedilol, probably the ß-blocker of choice for everyone with cirrhosis and portal hypertension: But not so fast!. LIVER INTERNATIONAL. 2023; 43(6)DOI:10.1111/liv.15582. PMID:37166136. IF:6.000(Q1/2D).

Torrico M.C., Fernández-Arévalo A., Ballart C., Solano M., Rojas E., Abras A., Gonzales F., Arnau A., Tebar S., Llovet T., Lozano D., Ariza-Vioque E., Gascón J., Picado A., Torrico F., Munoz, C, Gállego M.. Usefulness of Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry in the Characterization of Leishmania Strains Causing Tegumentary Leishmaniasis in Bolivia versus hsp70 Gene Sequencing. Microbiology Spectrum. 2023; 11(1)DOI:10.1128/spectrum.03477-22. PMID:36633426. IF:3.700(Q2/4D).

Becerra-Aparicio F., Gómez-Zorrilla S., Hernández-García M., Gijón D., Siverio A., Berbel D., Sánchez-Carrillo C., Cercenado E., Rivera A., de Malet A., Xercavins M., Ruiz de Gopegui E., Canoura-Fernández L., Martínez J.A., Seral C., Del Pozo J.L., Cotarelo M., Díaz-Regañón J., Cantón R., Oliver A., Horcajada J.P., Ruiz-Garbajosa P.. Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project). JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023; 78(9)DOI:10.1093/jac/dkad234. PMID:37533351. IF:3.900(Q1/3D).

Sojo-Dorado J., López-Hernández I., Hernández-Torres A., Retamar-Gentil P., Merino De Lucas E., Escolà-Verge L., Bereciartua E., García-Vázquez E., Pintado V., Boix-Palop L., Natera-Kindelán C., Sorlí L., Borrell N., Amador-Prous C., Shaw E., Jover-Saenz A., Molina J., Martínez-Álvarez R.M., Dueñas C.J., Calvo-Montes J., Lecuona M., Pomar V., Borreguero I., Palomo-Jimenez V., Docobo-Perez F., Pascual Á., Rodríguez-Baño J.. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023; 78(7)DOI:10.1093/jac/dkad147. PMID:37260299. IF:3.900(Q1/3D).

de Mendoza C., Carrizo P., Sauleda S., Richart A., Rando A., Miró E., Benito R., Ayerdi O., Encinas B., Aguilera A., Reina G., Rojo S., González R., Fernández-Ruiz M., Liendo P., Montiel N., Roc L., Treviño A., Pozuelo M.J., Soriano V.. The slowdown of new infections by human retroviruses has reached a plateau in Spain. JOURNAL OF MEDICAL VIROLOGY. 2023; 95(5)DOI:10.1002/jmv.28779. PMID:37212269. IF:6.800(Q1/1D).

Pérez-Recio S., Grijota-Camino M.D., Anibarro L., Rabuñal-Rey R., Sabria J., Gijón-Vidaurreta P., Pomar V., García-Gasalla M., Domínguez-Castellano Á., Trigo M., Santos M.J., Cebollero A., Rodríguez S., Moga E., Penas-Truque A., Martos C., Ruiz-Serrano M.J., Garcia-De-Cara E.I., Alcaide F., Santin M.. Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study. PLoS One. 2023; 18(8)DOI:10.1371/journal.pone.0285917. PMID:37647315. IF:2.900(Q1/3D).

Batlle M., Badia J.M., Hernández S., Grau S., Padulles A., Boix-Palop L., Giménez-Pérez M., Ferrer R., Calbo E., Limón E., Pujol M., Horcajada J.P., Smithson A., Ros N.B., Gomila-Grange A., Pomar V., Toboso S.H., Murgadella-Sancho A., Perez-Hita A.O., Temple M.D., Molpeceres S.V., Pardo D.R., Río A.D., Luque M.F.S., Blanco N.V., Acedo S.O., Guitart S.S., Nicolas E.M., Noblia-Gigena L.B., Pérez O.D.R., Rodriguez M.P.G., Barcons I.A., Serra N.J., Calva L.C., Lérida A., Torras S.G., Martínez L.H., Miñambres C., Matellane J.M., Jofre C.S., Estada S.B., Carrascosa M.C., Mota S.T., Barrena D.S.. Reducing the duration of antibiotic therapy in surgical patients through a specific nationwide antimicrobial stewardship program. A prospective, interventional cohort study. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023; 62(5)DOI:10.1016/j.ijantimicag.2023.106943. PMID:37541529. IF:4.900(Q1/2D).